MDL3
MDL3 is a novel inhibitor of PDE4B and PDE5A. MDL3 against liver injury and inflammation and inhibits the pathological remodeling of adipose tissue[1].
Product Specifications
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/mdl3.html
Smiles
CC1=NC(NC2=CC=C(CC(O)=O)C=C2)=NC(NC3=CC=C(F)C(C(F)(F)F)=C3)=C1C
Molecular Formula
C21H18F4N4O2
Molecular Weight
434.39
References & Citations
[1]Dalton W Staller, ET AL. A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases. Hepatology. 2024 Jul 1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
I-3101-1 1 mg
Ferritin Conjugated Wisteria floribunda Lectin (Japanese Wisteria) -WFA-
Ask
View Details ![Mouse Monoclonal Cyclin B1 Antibody (SPM619) [Allophycocyanin]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-11598APC 0.1 mL
Mouse Monoclonal Cyclin B1 Antibody (SPM619) [Allophycocyanin]
Ask
View Details 
